It is important to note, the tissue-specific modulation of lipid metabolism and WAT remodeling of GLP-1 represents a molecular mechanism in mediating GLP-1's anti-obesity actions (Decara et al., 2016; Xu et al., 2016). The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.